Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Hematologic Neoplasms
×
Standard of Care
×
Clear all
Filters
3
NCT03486873
2026-03-16
MK-3475-587
Merck Sharp & Dohme LLC
Phase 3
Recruiting
3,500 enrolled
NCT01254318
2016-11-02
TRAFIC
Merck Sharp & Dohme LLC
Completed
130 enrolled
5 charts